Cel-Sci
CVM
#10616
Rank
A$28.85 M
Marketcap
A$1.65
Share price
-4.92%
Change (1 day)
-88.68%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of March 2026 : A$25.2 Million

According to Cel-Sci 's latest financial reports the company's total assets are A$25.2 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-09-30A$42.59 M9.13%
2024-09-30A$39.02 M-17.82%
2023-09-30A$47.49 M-39.54%
2022-09-30A$78.55 M-25.13%
2021-09-30A$0.10 B85.49%
2020-09-30A$56.56 M38.28%
2019-09-30A$40.9 M-0.13%
2018-09-30A$40.95 M40.17%
2017-09-30A$29.21 M-10.32%
2016-09-30A$32.58 M-20.01%
2015-09-30A$40.73 M85.07%
2014-09-30A$22 M89.27%
2013-09-30A$11.62 M-25.05%
2012-09-30A$15.51 M-18.85%
2011-09-30A$19.11 M-51.23%
2010-09-30A$39.19 M-26.04%
2009-09-30A$53 M185.95%
2008-09-30A$18.53 M-20.03%
2007-09-30A$23.17 M79.13%
2006-09-30A$12.94 M217.79%
2005-09-30A$4.07 M-47.06%
2004-09-30A$7.69 M79.05%
2003-09-30A$4.29 M-38.07%
2002-09-30A$6.93 M-24.33%
2001-09-30A$9.16 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$285.95 B 1,134,426.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$131.67 B 522,306.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.04 B 4,061.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$42.25 M 67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$56.99 B 226,021.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$0.66 B 2,526.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.87 B 7,356.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$15 M-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA